FMO5 and chronic granulomatous disease: In conclusion, differentiation of CGD patient-specific iPSC to monocytes/macrophages offers a valuable complement to neutrophil differentiation that permits examination of the mechanisms controlling NADPH oxidase dysfunction in CGD patients with mutations in other subunits of this enzyme complex.